Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a multicenter, prospective, longitudinal, observational cohort study to investigate thrombosis and hemostasis diseases in Chinese patients. This study will collect basic information, diagnostic and treatment information, as well as medical expense information of patients from medical records.The incidence and risk factors of thrombosis and hemostasis diseases, the treatment methods, prognosis and medical expenses of these patients in China will be analyzed. The study will use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.

Who May Be Eligible (Plain English)

Who May Qualify: - Patients who were diagnosed as thrombosis and hemostasis diseases. Who Should NOT Join This Trial: - Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease. - Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements. - According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Patients who were diagnosed as thrombosis and hemostasis diseases. Exclusion Criteria: * Long-term follow-up information for patients is not available for any reason, such as not being available or having a serious concomitant disease. * Patients with alcohol and drug addictions or mental illness affect their ability to comply with study requirements. * According to the investigator, there are conditions that may endanger the patient's safety or affect his/her compliance.

Locations (5)

Peking University Insititute of Hematology, Peking University People's Hospital
Beijing, Beijing Municipality, China
Department of Hematology, Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Department of Hematology, Beijing Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Xinqiao Hospital, Army Military Medical University
Chongqing, China